- Report
- February 2024
- 250 Pages
Global
From €4834EUR$5,000USD£4,155GBP
- Report
- December 2023
- 200 Pages
Global
From €4834EUR$5,000USD£4,155GBP
- Report
- January 2024
- 143 Pages
Global
From €3769EUR$3,899USD£3,240GBP
- Report
- November 2023
- 145 Pages
Global
From €2416EUR$2,499USD£2,076GBP
- Report
- October 2023
- 143 Pages
Global
From €2416EUR$2,499USD£2,076GBP
- Report
- July 2023
- 139 Pages
Global
From €2416EUR$2,499USD£2,076GBP
- Report
- January 2024
- 220 Pages
Global
From €2407EUR$2,490USD£2,069GBP
- Report
- April 2024
- 185 Pages
Global
From €4737EUR$4,900USD£4,071GBP
- Report
- November 2023
- 190 Pages
Global
From €4737EUR$4,900USD£4,071GBP
- Report
- October 2023
- 190 Pages
Global
From €4737EUR$4,900USD£4,071GBP
- Report
- October 2023
- 190 Pages
Global
From €4737EUR$4,900USD£4,071GBP
- Report
- October 2023
- 189 Pages
Global
From €4737EUR$4,900USD£4,071GBP
- Report
- November 2023
- 181 Pages
Global
From €4737EUR$4,900USD£4,071GBP
- Report
- July 2023
- 170 Pages
Global
From €2417EUR$2,500USD£2,077GBP
- Report
- July 2023
- 110 Pages
Global
From €4350EUR$4,500USD£3,739GBP
- Report
- February 2024
- 116 Pages
Global
From €4592EUR$4,750USD£3,947GBP
- Report
- February 2024
- 111 Pages
Global
From €4592EUR$4,750USD£3,947GBP
- Report
- February 2024
- 130 Pages
Global
From €4592EUR$4,750USD£3,947GBP
- Report
- February 2024
- 120 Pages
Global
From €4592EUR$4,750USD£3,947GBP
- Report
- February 2024
- 120 Pages
Global
From €4592EUR$4,750USD£3,947GBP
Pneumonia is an infectious disease caused by bacteria, viruses, or fungi that affects the lungs. It is one of the most common infectious diseases and is a leading cause of death worldwide. Infectious disease testing is used to diagnose and monitor the progression of pneumonia. Tests used to diagnose pneumonia include chest X-rays, sputum cultures, and blood tests. Treatment for pneumonia typically involves antibiotics, antivirals, and other medications.
The pneumonia market within the context of infectious disease testing is a rapidly growing market. It is driven by the increasing prevalence of pneumonia, the development of new diagnostic technologies, and the increasing demand for rapid and accurate diagnosis. The market is expected to grow due to the increasing prevalence of pneumonia, the development of new diagnostic technologies, and the increasing demand for rapid and accurate diagnosis.
Some companies in the pneumonia market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more